Therapeutic effects of eperisone on pulmonary fibrosis via preferential suppression of fibroblast activity
Ken-ichiro Tanaka 1, *, Mikako Shimoda 1, Toshifumi Sugizaki 1, Maki Ikeda 1, Ayaka Takafuji 1, Masahiro Kawahara 1, Naoki Yamakawa 2, and Tohru Mizushima 3.
1Laboratory of Bio-Analytical Chemistry, Research Institute of Pharmaceutical Sciences, Faculty of Pharmacy, Musashino University, 1-1-20 Shinmachi, Nishi-Tokyo 202-8585, Japan;2Shujitsu University School of Pharmacy, Okayama 703-8516, Japan; 3 LTT Bio-Pharma Co., Ltd, Shiodome Building 3F, 1-2-20 Kaigan, Minato-ku, Tokyo 105-0022, Japan.